Advanced Search

Submit Manuscript

ADVANCE ONLINE PUBLICATION

RESEARCH HIGHLIGHTS

Towards clinically meaningful expansion of human HSCs

Maria Florencia Tellechea , Jalila Chagraoui , Sandra Cohen , Guy Sauvageau

Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada
* Correspondence: Guy Sauvageau(guy.sauvageau@umontreal.ca)

Improved strategies for ex vivo expansion of human hematopoietic stem cells (HSCs) are necessary to supply the large demand of cells required for certain clinical applications such as gene therapy/editing and cord blood (CB) transplantation. In a recent paper published in Nature, Sakurai et al. reported that the combination of three small molecules, namely a phosphoinositide 3-kinase activator peptide, a thrombopoietin receptor agonist and the pyrimidoindole derivative UM171, was sufficient to stimulate the expansion of umbilical CB HSCs, providing the first chemically defined cytokine-free expansion medium for human HSCs.

https://doi.org/10.1038/s41422-023-00817-z

FULL TEXT | PDF

Browse 245